
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter H - Medical Devices
#### PART 812 - INVESTIGATIONAL DEVICE EXEMPTIONS
##### Subpart B - Application and Administrative Action
###### ยง 812.36 Treatment use of an investigational device.
####### Reporting requirements.

(f)The sponsor of a treatment IDE shall submit progress reports on a semi-annual basis to all reviewing IRB's and FDA until the filing of a marketing application. These reports shall be based on the period of time since initial approval of the treatment IDE and shall include the number of patients treated with the device under the treatment IDE, the names of the investigators participating in the treatment IDE, and a brief description of the sponsor's efforts to pursue marketing approval/clearance of the device. Upon filing of a marketing application, progress reports shall be submitted annually in accordance with ยง 812.150(b)(5). The sponsor of a treatment IDE is responsible for submitting all other reports required under ยง 812.150.
